BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: López-Serrano P, Pérez-Calle JL, Sánchez-Tembleque MD. Hepatitis B and inflammatory bowel disease: Role of antiviral prophylaxis. World J Gastroenterol 2013; 19(9): 1342-1348 [PMID: 23538480 DOI: 10.3748/wjg.v19.i9.1342]
URL: https://www.wjgnet.com/1948-5182/full/v19/i9/1342.htm
Number Citing Articles
1
Michelle C.M. Cheung, Kosh Agarwal. Liver abnormalities in the immunosuppressedBest Practice & Research Clinical Gastroenterology 2013; 27(4): 597 doi: 10.1016/j.bpg.2013.06.017
2
Ruwaida Ben Musa, Anuhya Gampa, Sanjib Basu, Ali Keshavarzian, Garth Swanson, Michael Brown, Rana Abraham, Keith Bruninga, John Losurdo, Mark DeMeo, Sohrab Mobarhan, David Shapiro, Ece Mutlu. Hepatitis B vaccination in patients with inflammatory bowel diseaseWorld Journal of Gastroenterology 2014; 20(41): 15358-15366 doi: 10.3748/wjg.v20.i41.15358
3
S. K. Sarin, M. Kumar, G. K. Lau, Z. Abbas, H. L. Y. Chan, C. J. Chen, D. S. Chen, H. L. Chen, P. J. Chen, R. N. Chien, A. K. Dokmeci, Ed Gane, J. L. Hou, W. Jafri, J. Jia, J. H. Kim, C. L. Lai, H. C. Lee, S. G. Lim, C. J. Liu, S. Locarnini, M. Al Mahtab, R. Mohamed, M. Omata, J. Park, T. Piratvisuth, B. C. Sharma, J. Sollano, F. S. Wang, L. Wei, M. F. Yuen, S. S. Zheng, J. H. Kao. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateHepatology International 2016; 10(1): 1 doi: 10.1007/s12072-015-9675-4
4
Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng. IBD barriers across the continents – East AsiaTherapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231212089
5
Evidence‐based consensus on opportunistic infections in inflammatory bowel diseaseJournal of Digestive Diseases 2018; 19(2): 54 doi: 10.1111/1751-2980.12578
6
Juozas Grigas, Maria Montoya, Evelina Simkute, Marius Buitkus, Ruta Zagrabskaite, Arnoldas Pautienius, Dainius Razukevicius, Laimas Virginijus Jonaitis, Gediminas Kiudelis, Jurgita Skieceviciene, Ruta Vaiciuniene, Asta Stankuviene, Inga Arune Bumblyte, Juozas Kupcinskas, Arunas Stankevicius. Molecular Characterization and Seroprevalence of Hepatitis E Virus in Inflammatory Bowel Disease Patients and Solid Organ Transplant RecipientsViruses 2021; 13(4): 670 doi: 10.3390/v13040670
7
Jing Fang, Wenge Li, Xiangxin Peng, Zhao Tan, Min Tan, Cong Zhang, Wenbo Wang, Zhihong Xu, Gumin Zhou. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysisInternational Urology and Nephrology 2017; 49(3): 475 doi: 10.1007/s11255-016-1487-5
8
Jing Fang, Wenge Li, Min Tan, Xiangxin Peng, Zhao Tan, Wenbo Wang. Effect of different hepatitis B infection status on the prognosis of active lupus nephritis treated with immunosuppression: a retrospective analysis of 177 patientsInternational Journal of Rheumatic Diseases 2018; 21(5): 1060 doi: 10.1111/1756-185X.13313
9
Claudio Bonifati, Viviana Lora, Dario Graceffa, Lorenzo Nosotti. Management of psoriasis patients with hepatitis B or hepatitis C virus infectionWorld Journal of Gastroenterology 2016; 22(28): 6444-6455 doi: 10.3748/wjg.v22.i28.6444
10
Vlad Alexandru Ionescu, Gina Gheorghe, Valentin Nicolae Varlas, Ana Maria Alexandra Stanescu, Camelia Cristina Diaconu. Hepatobiliary Impairments in Patients with Inflammatory Bowel Diseases: The Current ApproachGastroenterology Insights 2022; 14(1): 13 doi: 10.3390/gastroent14010002
11
Miguel Cordero-Coma, Raquel Salazar-Méndez, Taygan Yilmaz. Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issuesExpert Opinion on Drug Safety 2015; 14(9): 1353 doi: 10.1517/14740338.2015.1061992
12
Kazuyuki Suzuki, Ichiro Kumagai, Yuichi Yoshida, Akio Miyasaka, Yasuhiro Takikawa, Ryoichi Kamiya, Kouryo Kondo, Akinobu Kato, Toshimi Chiba, Hiroaki Okamoto. Asymptomatic acute hepatitis E in a female patient with ulcerative colitisClinical Journal of Gastroenterology 2017; 10(3): 255 doi: 10.1007/s12328-017-0730-7
13
Marisa E. Luck, Stefan A. Muljo, Colm B. Collins. Prospects for Therapeutic Targeting of MicroRNAs in Human Immunological DiseasesThe Journal of Immunology 2015; 194(11): 5047 doi: 10.4049/jimmunol.1403146
14
J.K. Yamamoto-Furusho, F. Bosques-Padilla, P. Daffra, J.A. De Paula, J. Etchevers, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.M. Marroquín de la Garza, R. Monreal Robles, J.L. Rocha, F. Steinwurz, R. Vázquez-Frías, G. Veitia, C. Zaltman. Situaciones especiales en la enfermedad inflamatoria intestinal: primer consenso latinoamericano de la Pan American Crohn's and Colitis Organisation (PANCCO) (Segunda parte)Revista de Gastroenterología de México 2017; 82(2): 134 doi: 10.1016/j.rgmx.2016.07.005
15
Evidence-based consensus on opportunistic infections in inflammatory bowel disease (republication)Intestinal Research 2018; 16(2): 178 doi: 10.5217/ir.2018.16.2.178
16
Ji Young Chang, Sung-Ae Jung, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim. Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in KoreaIntestinal Research 2018; 16(4): 599 doi: 10.5217/ir.2018.00012
17
Douglas L. Nguyen, Emily T. Nguyen, Matthew L. Bechtold. Effect of Immunosuppressive Therapies for the Treatment of Inflammatory Bowel Disease on Response to Routine Vaccinations: A Meta-AnalysisDigestive Diseases and Sciences 2015; 60(8): 2446 doi: 10.1007/s10620-015-3631-y
18
Pilar López-Serrano, Elsa de la Fuente Briongos, Elisa Carrera Alonso, Jose Lázaro Pérez-Calle, Conrado Fernández Rodríguez. Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapyWorld Journal of Hepatology 2015; 7(3): 539-547 doi: 10.4254/wjh.v7.i3.539
19
Adérson Omar Mourão Cintra Damião. A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapyMedical Science Monitor 2014; 20: 487 doi: 10.12659/MSM.890331
20
Carlos Walter Sobrado, Natália Sousa Freitas Queiroz, Caio Almeida Perez. Biological Therapy for Inflammatory Bowel Disease2020;  doi: 10.5772/intechopen.90204
21
Leilei Zhu, Gil Y. Melmed. Treatment of Inflammatory Bowel Disease with Biologics2018; : 315 doi: 10.1007/978-3-319-60276-9_18
22
Luigi Marongiu, Sascha Venturelli, Heike Allgayer. Involvement of HHV-4 (Epstein–Barr Virus) and HHV-5 (Cytomegalovirus) in Inflammatory Bowel Disease and Colorectal Cancer: A Meta-AnalysisCancers 2022; 14(20): 5085 doi: 10.3390/cancers14205085
23
Mohammad Shehab, Fatema Alrashed, Munerah Alyaseen, Zainab Safar, Tunrayo Adekunle, Ahmad Alfadhli, Talat Bessissow. Immunogenicity of Hepatitis B Vaccination in Patients with Ulcerative Colitis on Infliximab Is Attenuated Compared to Those on 5-Aminosalicylic Acid Therapies: A Prospective Observational StudyVaccines 2024; 12(4): 364 doi: 10.3390/vaccines12040364
24
Jing Fang, Wenge Li, Min Tan, Wen Chen, Cong Zhang, Wenbo Wang, Qianqian Xu, Xinzhen Guo. Discontinuation of antiviral prophylaxis increased the risk of hepatitis B virus reactivation in glomerulonephritis patients under immunotherapy: a real-life observationInternational Urology and Nephrology 2018; 50(9): 1653 doi: 10.1007/s11255-018-1867-0
25
J.K. Yamamoto-Furusho, F. Bosques-Padilla, P. Daffra, J.A. De Paula, J. Etchevers, M.T. Galiano, P. Ibañez, F. Juliao, P.G. Kotze, J.M. Marroquín de la Garza, R. Monreal Robles, J.L. Rocha, F. Steinwurz, R. Vázquez-Frías, G. Veitia, C. Zaltman. Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part)Revista de Gastroenterología de México (English Edition) 2017; 82(2): 134 doi: 10.1016/j.rgmxen.2016.07.004